Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ruby Tuesday Insider Shows Confidence Amidst Struggles

Ruby Tuesday insider trading: Ruby Tuesday, Inc. (NYSE:RT) made negative headlines recently when it announced its first quarter 2014 earnings. Nevertheless, some analysts claim,management is repositioning the company and rolling out a value-oriented menu in hopes that they can get their core customer to return.” Jill Golder seems confident, as she purchased 5,000 shares of common stock on Friday, at $6.05 per share, bringing her total holdings in the firm to 30,324 shares.

Ruby Tuesday, Inc. (NYSE:RT)

After Friday’s acquisition, the Senior Vice President for Finance had holdings amounting to approximately $183,460 when the market closed. This insider purchase comes as a surprise and could serve as a boost in confidence for the company’s stock, which is currently trading very near its 52-week low of $6 per share. While trading at 0.3 times its trailing sales, the company is available at a huge price discount of 87.5% relative to its industry average.

The price discount is indicative of Ruby Tuesday’s problems and the 60% loss in share value the stock has experienced over the past three months. Some believe the firm can manage to turn things around and reclaim their customers, however, recent figures show a 10.4% decline in traffic. The firm announced declines in same-restaurant sales and seems to be sustaining its current share value only due to its real-estate assets.

Disclosure: Pablo Erbar holds no position in any stocks mentioned

Recommended Reading:

Symetra Financial Earnings Follow This CIO’s Purchase

Insider Trading a Constant at Monmouth

7 Insider Moves You Should Pay Attention To

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!